腺病毒载体口蹄疫疫苗平台跨血清型与拓扑型通用性研究
在约90%接种牛(n=375)中诱导同源中和抗体,75%受试疫苗的完全保护有效剂量等于或低于AdtA24最低保护剂量。结果证实该平台在5个血清型中可区分感染与接种动物(DIVA)。
要点
- 16种AdtFMD疫苗在约90%接种牛(n=375)中诱导同源中和抗体。
- 75%受试疫苗的100%临床保护有效剂量等于或低于AdtA24最低保护剂量。
- 平台在5个评估血清型中具备DIVA能力。
核心结论
- AdtFMD疫苗平台在评估的血清型和拓扑型中展现通用性,支持进一步开发、许可及用于口蹄疫暴发控制和根除。
研究设计与样本
- 在22项效力研究中,13项于接种后2周用同源FMDV株对 naïve 对照和AdtFMD接种牛进行舌皮内攻毒。
主要发现
- 16种AdtFMD疫苗均在约90%总接种牛(n=375)的攻毒日血清中检出同源中和抗体。
- 75%受试疫苗的100%临床FMD保护有效剂量等于或低于含ENABL®佐剂的AdtA24条件许可疫苗最低保护剂量。
- 结果确认AdtFMD平台在5个评估FMDV血清型中可区分感染与接种动物(DIVA)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We investigated the serotype- and topotype versatility of a replication-deficient human adenovirus serotype 5 vectored foot-and-mouth disease (FMD) vaccine platform (AdtFMD). Sixteen AdtFMD recombinant subunit monovalent vaccines targeting twelve distinct FMD virus (FMDV) serotype/topotypes in FMD Regional Pools I-VII were constructed. The AdtA24 serotype conditionally licensed vaccine served as the basis for vaccine design and target dose for cattle clinical trials. Several vaccines contained an additional RGD motif genetic insertion in the adenovector fiber knob, and/or a full-length 2B gene insertion in the FMDV P1 gene cassette. In 13 of the 22 efficacy studies conducted, naïve control and AdtFMD vaccinated cattle were challenged intradermolingually at 2 weeks post-vaccination using a FMDV strain homologous to the AdtFMD vaccine strain. Each of the 16 AdtFMD vaccines were immunogenic based on the presence of homologous neutralizing antibodies in the serum of approximately 90% of total vaccinates (n = 375) on the day of challenge. Importantly, for 75% of vaccines tested, the effective dose that conferred 100% protection against clinical FMD was identical to or in some cases lower than, the minimum protective dose for the conditionally licensed AdtA24 vaccine formulated with ENABL® adjuvant. Results also confirmed the capability of the AdtFMD vaccine platform to differentiate infected from vaccinated animals (DIVA) across the five FMDV serotypes evaluated. Collectively, this comprehensive set of FMD cattle vaccine dose ranging studies highlights the serotype- and topotype versatility of the AdtFMD vaccine platform for further development, licensure, and application in FMD outbreak control and disease eradication efforts.
引用
- Barrera J, Brake DA, Schutta C, et al. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine. Vaccine. 2018. PMID: 30327212. doi:10.1016/j.vaccine.2018.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。